

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of hippo signaling (GO:0035330) | 4.48826064 |
| 2 | otic vesicle formation (GO:0030916) | 4.46825095 |
| 3 | glomerular basement membrane development (GO:0032836) | 4.19382629 |
| 4 | limb bud formation (GO:0060174) | 4.15701269 |
| 5 | growth hormone receptor signaling pathway (GO:0060396) | 4.01864985 |
| 6 | prostate gland growth (GO:0060736) | 3.85921024 |
| 7 | behavioral response to nicotine (GO:0035095) | 3.73478386 |
| 8 | cornea development in camera-type eye (GO:0061303) | 3.64884318 |
| 9 | cellular response to growth hormone stimulus (GO:0071378) | 3.56038991 |
| 10 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.42314621 |
| 11 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 3.30304416 |
| 12 | lateral sprouting from an epithelium (GO:0060601) | 3.29187368 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 3.25233881 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 3.25233881 |
| 15 | tryptophan catabolic process (GO:0006569) | 3.25233881 |
| 16 | kidney morphogenesis (GO:0060993) | 3.23153863 |
| 17 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.19606609 |
| 18 | detection of light stimulus involved in visual perception (GO:0050908) | 3.11938015 |
| 19 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.11938015 |
| 20 | auditory receptor cell stereocilium organization (GO:0060088) | 3.07991695 |
| 21 | indolalkylamine metabolic process (GO:0006586) | 3.07382185 |
| 22 | regulation of activation of Janus kinase activity (GO:0010533) | 3.05143336 |
| 23 | mesonephros development (GO:0001823) | 3.03265106 |
| 24 | radial glial cell differentiation (GO:0060019) | 2.93727138 |
| 25 | fucose catabolic process (GO:0019317) | 2.92558084 |
| 26 | L-fucose metabolic process (GO:0042354) | 2.92558084 |
| 27 | L-fucose catabolic process (GO:0042355) | 2.92558084 |
| 28 | skeletal muscle adaptation (GO:0043501) | 2.86849612 |
| 29 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.85728104 |
| 30 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.85728104 |
| 31 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.85728104 |
| 32 | bicarbonate transport (GO:0015701) | 2.85658831 |
| 33 | lung secretory cell differentiation (GO:0061140) | 2.85091858 |
| 34 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.85073840 |
| 35 | kynurenine metabolic process (GO:0070189) | 2.84656113 |
| 36 | inner ear receptor stereocilium organization (GO:0060122) | 2.80596730 |
| 37 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.78384207 |
| 38 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.78336365 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 2.77436800 |
| 40 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.76144180 |
| 41 | epithelial cilium movement (GO:0003351) | 2.74197316 |
| 42 | axoneme assembly (GO:0035082) | 2.74017357 |
| 43 | tryptophan metabolic process (GO:0006568) | 2.73988100 |
| 44 | thyroid hormone metabolic process (GO:0042403) | 2.72378009 |
| 45 | sulfation (GO:0051923) | 2.71719612 |
| 46 | photoreceptor cell maintenance (GO:0045494) | 2.68919159 |
| 47 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 2.65804613 |
| 48 | reflex (GO:0060004) | 2.62635973 |
| 49 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.61687884 |
| 50 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.61348160 |
| 51 | negative regulation of mast cell activation (GO:0033004) | 2.57689909 |
| 52 | ketone body metabolic process (GO:1902224) | 2.56919644 |
| 53 | organ growth (GO:0035265) | 2.55529846 |
| 54 | urinary tract smooth muscle contraction (GO:0014848) | 2.54063814 |
| 55 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.52940703 |
| 56 | white fat cell differentiation (GO:0050872) | 2.52323168 |
| 57 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.50953708 |
| 58 | positive regulation of digestive system process (GO:0060456) | 2.50563789 |
| 59 | regulation of gene silencing by miRNA (GO:0060964) | 2.49659341 |
| 60 | regulation of gene silencing by RNA (GO:0060966) | 2.49659341 |
| 61 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.49659341 |
| 62 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.49377987 |
| 63 | dendritic spine morphogenesis (GO:0060997) | 2.47937819 |
| 64 | nonmotile primary cilium assembly (GO:0035058) | 2.46576684 |
| 65 | cilium movement (GO:0003341) | 2.45214605 |
| 66 | thyroid hormone generation (GO:0006590) | 2.43443684 |
| 67 | regulation of memory T cell differentiation (GO:0043380) | 2.42759000 |
| 68 | amine catabolic process (GO:0009310) | 2.41334565 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 2.41334565 |
| 70 | phasic smooth muscle contraction (GO:0014821) | 2.41148362 |
| 71 | indole-containing compound metabolic process (GO:0042430) | 2.40180296 |
| 72 | embryonic camera-type eye development (GO:0031076) | 2.39975322 |
| 73 | cilium morphogenesis (GO:0060271) | 2.39349871 |
| 74 | protein K11-linked deubiquitination (GO:0035871) | 2.38208526 |
| 75 | neuronal action potential (GO:0019228) | 2.34008358 |
| 76 | embryonic digestive tract morphogenesis (GO:0048557) | 2.33807015 |
| 77 | regulation of action potential (GO:0098900) | 2.33533435 |
| 78 | response to pheromone (GO:0019236) | 2.32924897 |
| 79 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.32533666 |
| 80 | somite development (GO:0061053) | 2.30729635 |
| 81 | cilium organization (GO:0044782) | 2.30322149 |
| 82 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.27182156 |
| 83 | dorsal/ventral axis specification (GO:0009950) | 2.26735972 |
| 84 | cilium assembly (GO:0042384) | 2.26643256 |
| 85 | lymphangiogenesis (GO:0001946) | 2.25497806 |
| 86 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.24896674 |
| 87 | one-carbon compound transport (GO:0019755) | 2.23437433 |
| 88 | positive regulation of protein kinase C signaling (GO:0090037) | 2.23314561 |
| 89 | visual perception (GO:0007601) | 2.23280425 |
| 90 | cAMP catabolic process (GO:0006198) | 2.23212812 |
| 91 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.22687417 |
| 92 | transepithelial transport (GO:0070633) | 2.22338385 |
| 93 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.22319768 |
| 94 | head development (GO:0060322) | 2.22152776 |
| 95 | appendage development (GO:0048736) | 2.21758231 |
| 96 | limb development (GO:0060173) | 2.21758231 |
| 97 | photoreceptor cell development (GO:0042461) | 2.21695052 |
| 98 | metanephric nephron tubule development (GO:0072234) | 2.21154489 |
| 99 | metanephric tubule development (GO:0072170) | 2.21154489 |
| 100 | sensory perception of light stimulus (GO:0050953) | 2.20725730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.98299353 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.84034432 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80136192 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.70429507 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.32642879 |
| 6 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.30651923 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.14845486 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.96770226 |
| 9 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.90623093 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89189892 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.87102411 |
| 12 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82411885 |
| 13 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.71741386 |
| 14 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.68322410 |
| 15 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68114717 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64675122 |
| 17 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.63826404 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61672176 |
| 19 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.61020625 |
| 20 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57586251 |
| 21 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56282041 |
| 22 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55269969 |
| 23 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52213009 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.51972880 |
| 25 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.51776760 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51436758 |
| 27 | STAT3_23295773_ChIP-Seq_U87_Human | 1.50590432 |
| 28 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50552626 |
| 29 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49185652 |
| 30 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.49145572 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49085753 |
| 32 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44392156 |
| 33 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.44392156 |
| 34 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44073476 |
| 35 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42859976 |
| 36 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.42324890 |
| 37 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.41219591 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40304631 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38221573 |
| 40 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.32930710 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32796206 |
| 42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31987617 |
| 43 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31072939 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.27483699 |
| 45 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25911272 |
| 46 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.25381917 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25093676 |
| 48 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24678793 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22607111 |
| 50 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.22060558 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22047349 |
| 52 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.21998836 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21760001 |
| 54 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21731091 |
| 55 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.20622550 |
| 56 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.20271153 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18435851 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17757234 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17715376 |
| 60 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16086031 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12170140 |
| 62 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11149575 |
| 63 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 1.10463031 |
| 64 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.09796937 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09519796 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09250634 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08518459 |
| 68 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08209169 |
| 69 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08040587 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08033430 |
| 71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07799482 |
| 72 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07799482 |
| 73 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07459116 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06202723 |
| 75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.05767219 |
| 76 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05752566 |
| 77 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05477842 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05074252 |
| 79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.04824634 |
| 80 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04796623 |
| 81 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03744926 |
| 82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03744926 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03403076 |
| 84 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.02447503 |
| 85 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02271063 |
| 86 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02132855 |
| 87 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.00931873 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00557796 |
| 89 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99404147 |
| 90 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98155941 |
| 91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97857141 |
| 92 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97702487 |
| 93 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.97240033 |
| 94 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96318837 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96130036 |
| 96 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95287054 |
| 97 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95280244 |
| 98 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95209444 |
| 99 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95082021 |
| 100 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94860631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005377_hearing/vestibular/ear_phenot | 4.56958655 |
| 2 | MP0003878_abnormal_ear_physiology | 4.56958655 |
| 3 | MP0002102_abnormal_ear_morphology | 3.58687058 |
| 4 | MP0002254_reproductive_system_inflammat | 2.82732622 |
| 5 | MP0005248_abnormal_Harderian_gland | 2.79873172 |
| 6 | MP0004885_abnormal_endolymph | 2.38259860 |
| 7 | MP0002653_abnormal_ependyma_morphology | 2.35577217 |
| 8 | MP0003195_calcinosis | 2.28170347 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 2.22664184 |
| 10 | MP0000383_abnormal_hair_follicle | 2.14871026 |
| 11 | MP0004043_abnormal_pH_regulation | 2.14267468 |
| 12 | MP0003646_muscle_fatigue | 2.09342544 |
| 13 | MP0000566_synostosis | 2.06277829 |
| 14 | MP0003011_delayed_dark_adaptation | 2.05825365 |
| 15 | MP0000427_abnormal_hair_cycle | 1.97582882 |
| 16 | MP0010030_abnormal_orbit_morphology | 1.85832263 |
| 17 | MP0000569_abnormal_digit_pigmentation | 1.85245920 |
| 18 | MP0005083_abnormal_biliary_tract | 1.81510605 |
| 19 | MP0005253_abnormal_eye_physiology | 1.76823928 |
| 20 | MP0001968_abnormal_touch/_nociception | 1.74700434 |
| 21 | MP0002638_abnormal_pupillary_reflex | 1.73309877 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.68551773 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.67422006 |
| 24 | MP0003136_yellow_coat_color | 1.66414380 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.65003823 |
| 26 | MP0005503_abnormal_tendon_morphology | 1.58400988 |
| 27 | MP0006072_abnormal_retinal_apoptosis | 1.55796977 |
| 28 | MP0001485_abnormal_pinna_reflex | 1.44664427 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.43624892 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.43326680 |
| 31 | MP0010678_abnormal_skin_adnexa | 1.40881380 |
| 32 | MP0002938_white_spotting | 1.38287205 |
| 33 | MP0001756_abnormal_urination | 1.37751909 |
| 34 | MP0008995_early_reproductive_senescence | 1.36119564 |
| 35 | MP0000026_abnormal_inner_ear | 1.34557260 |
| 36 | MP0004133_heterotaxia | 1.31500865 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.31468652 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.31169809 |
| 39 | MP0000631_abnormal_neuroendocrine_gland | 1.29439620 |
| 40 | MP0003938_abnormal_ear_development | 1.21250848 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.20206579 |
| 42 | MP0006292_abnormal_olfactory_placode | 1.19768064 |
| 43 | MP0005379_endocrine/exocrine_gland_phen | 1.15271025 |
| 44 | MP0000230_abnormal_systemic_arterial | 1.13997276 |
| 45 | MP0003045_fibrosis | 1.13956998 |
| 46 | MP0004742_abnormal_vestibular_system | 1.13525307 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.12537581 |
| 48 | MP0008872_abnormal_physiological_respon | 1.10040914 |
| 49 | MP0003724_increased_susceptibility_to | 1.06988162 |
| 50 | MP0002295_abnormal_pulmonary_circulatio | 1.06772280 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.06094906 |
| 52 | MP0003137_abnormal_impulse_conducting | 1.05639520 |
| 53 | MP0002282_abnormal_trachea_morphology | 1.05280142 |
| 54 | MP0008775_abnormal_heart_ventricle | 1.05145202 |
| 55 | MP0001984_abnormal_olfaction | 1.05081146 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.03468854 |
| 57 | MP0004147_increased_porphyrin_level | 1.03435984 |
| 58 | MP0002736_abnormal_nociception_after | 1.01900126 |
| 59 | MP0001919_abnormal_reproductive_system | 1.01470814 |
| 60 | MP0010368_abnormal_lymphatic_system | 1.00332231 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.00168048 |
| 62 | MP0001346_abnormal_lacrimal_gland | 0.97497681 |
| 63 | MP0004215_abnormal_myocardial_fiber | 0.95651543 |
| 64 | MP0001661_extended_life_span | 0.95309484 |
| 65 | MP0001879_abnormal_lymphatic_vessel | 0.94093963 |
| 66 | MP0000613_abnormal_salivary_gland | 0.93169723 |
| 67 | MP0003787_abnormal_imprinting | 0.92690602 |
| 68 | MP0001963_abnormal_hearing_physiology | 0.92283801 |
| 69 | MP0009745_abnormal_behavioral_response | 0.91860896 |
| 70 | MP0004085_abnormal_heartbeat | 0.91192964 |
| 71 | MP0002933_joint_inflammation | 0.90370222 |
| 72 | MP0002168_other_aberrant_phenotype | 0.89086842 |
| 73 | MP0001486_abnormal_startle_reflex | 0.88975343 |
| 74 | MP0001177_atelectasis | 0.87565793 |
| 75 | MP0009384_cardiac_valve_regurgitation | 0.84293430 |
| 76 | MP0008961_abnormal_basal_metabolism | 0.84109005 |
| 77 | MP0005171_absent_coat_pigmentation | 0.83830981 |
| 78 | MP0002557_abnormal_social/conspecific_i | 0.83809716 |
| 79 | MP0001324_abnormal_eye_pigmentation | 0.82367188 |
| 80 | MP0002272_abnormal_nervous_system | 0.81756120 |
| 81 | MP0008877_abnormal_DNA_methylation | 0.80797925 |
| 82 | MP0005391_vision/eye_phenotype | 0.80009787 |
| 83 | MP0003119_abnormal_digestive_system | 0.79199187 |
| 84 | MP0005389_reproductive_system_phenotype | 0.78928659 |
| 85 | MP0000470_abnormal_stomach_morphology | 0.78726356 |
| 86 | MP0004484_altered_response_of | 0.78156386 |
| 87 | MP0001970_abnormal_pain_threshold | 0.78025601 |
| 88 | MP0002098_abnormal_vibrissa_morphology | 0.77963308 |
| 89 | MP0005195_abnormal_posterior_eye | 0.77820417 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.77136676 |
| 91 | MP0009046_muscle_twitch | 0.76969977 |
| 92 | MP0003936_abnormal_reproductive_system | 0.76176338 |
| 93 | MP0003879_abnormal_hair_cell | 0.75786004 |
| 94 | MP0004142_abnormal_muscle_tone | 0.74938239 |
| 95 | MP0004019_abnormal_vitamin_homeostasis | 0.74125899 |
| 96 | MP0004130_abnormal_muscle_cell | 0.73223634 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 0.72152456 |
| 98 | MP0002733_abnormal_thermal_nociception | 0.71776980 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.71352417 |
| 100 | MP0001664_abnormal_digestion | 0.70837352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic cysts (HP:0001737) | 4.14983589 |
| 2 | Concave nail (HP:0001598) | 4.05952965 |
| 3 | Congenital stationary night blindness (HP:0007642) | 3.93663772 |
| 4 | Nephronophthisis (HP:0000090) | 3.89968418 |
| 5 | True hermaphroditism (HP:0010459) | 3.80558947 |
| 6 | Molar tooth sign on MRI (HP:0002419) | 3.74008522 |
| 7 | Abnormality of midbrain morphology (HP:0002418) | 3.74008522 |
| 8 | Tubular atrophy (HP:0000092) | 3.67765543 |
| 9 | Abnormality of the renal medulla (HP:0100957) | 3.65498711 |
| 10 | Pancreatic fibrosis (HP:0100732) | 3.65440158 |
| 11 | Hyperventilation (HP:0002883) | 3.59265883 |
| 12 | Chronic hepatic failure (HP:0100626) | 3.54364397 |
| 13 | Abnormality of the renal cortex (HP:0011035) | 3.47007899 |
| 14 | Abnormal drinking behavior (HP:0030082) | 3.10261997 |
| 15 | Polydipsia (HP:0001959) | 3.10261997 |
| 16 | Cystic liver disease (HP:0006706) | 3.03075889 |
| 17 | Thyroid-stimulating hormone excess (HP:0002925) | 2.98584060 |
| 18 | Decreased circulating renin level (HP:0003351) | 2.96735103 |
| 19 | Keratoconus (HP:0000563) | 2.95770265 |
| 20 | Increased corneal curvature (HP:0100692) | 2.95770265 |
| 21 | Attenuation of retinal blood vessels (HP:0007843) | 2.79343955 |
| 22 | Stage 5 chronic kidney disease (HP:0003774) | 2.74814772 |
| 23 | Genetic anticipation (HP:0003743) | 2.70510214 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 2.55037829 |
| 25 | Tachypnea (HP:0002789) | 2.47180734 |
| 26 | Abolished electroretinogram (ERG) (HP:0000550) | 2.46293048 |
| 27 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.40751684 |
| 28 | Type II lissencephaly (HP:0007260) | 2.39501663 |
| 29 | Clumsiness (HP:0002312) | 2.39421447 |
| 30 | Polyuria (HP:0000103) | 2.39166182 |
| 31 | Congenital hepatic fibrosis (HP:0002612) | 2.38819676 |
| 32 | Flat capital femoral epiphysis (HP:0003370) | 2.37672772 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 2.34706016 |
| 34 | Mesangial abnormality (HP:0001966) | 2.31456273 |
| 35 | Large for gestational age (HP:0001520) | 2.23146685 |
| 36 | Gaze-evoked nystagmus (HP:0000640) | 2.22236748 |
| 37 | Partial duplication of thumb phalanx (HP:0009944) | 2.18895060 |
| 38 | Decreased central vision (HP:0007663) | 2.17423283 |
| 39 | Tubulointerstitial fibrosis (HP:0005576) | 2.15088756 |
| 40 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.15022548 |
| 41 | Protruding tongue (HP:0010808) | 2.13350687 |
| 42 | Conical tooth (HP:0000698) | 2.12132736 |
| 43 | Glomerulonephritis (HP:0000099) | 2.11807377 |
| 44 | Preaxial foot polydactyly (HP:0001841) | 2.10194296 |
| 45 | Patellar aplasia (HP:0006443) | 2.09969773 |
| 46 | Absent speech (HP:0001344) | 2.09852797 |
| 47 | Tubulointerstitial nephritis (HP:0001970) | 2.05343286 |
| 48 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.02414423 |
| 49 | Postaxial foot polydactyly (HP:0001830) | 2.01818745 |
| 50 | Abnormality of renin-angiotensin system (HP:0000847) | 2.01258644 |
| 51 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.00757636 |
| 52 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.99536614 |
| 53 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.99481268 |
| 54 | Genital tract atresia (HP:0001827) | 1.95857998 |
| 55 | Partial duplication of the phalanx of hand (HP:0009999) | 1.95001626 |
| 56 | Broad-based gait (HP:0002136) | 1.93469648 |
| 57 | Amelogenesis imperfecta (HP:0000705) | 1.92937390 |
| 58 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.92900137 |
| 59 | Occipital encephalocele (HP:0002085) | 1.92890202 |
| 60 | Abnormality of incisor morphology (HP:0011063) | 1.92864333 |
| 61 | Vaginal atresia (HP:0000148) | 1.91636770 |
| 62 | Furrowed tongue (HP:0000221) | 1.91518516 |
| 63 | Inability to walk (HP:0002540) | 1.91110106 |
| 64 | Male pseudohermaphroditism (HP:0000037) | 1.90781688 |
| 65 | Tubulointerstitial abnormality (HP:0001969) | 1.90559342 |
| 66 | Hypoplastic ischia (HP:0003175) | 1.90280451 |
| 67 | Short hallux (HP:0010109) | 1.88842343 |
| 68 | Absent/shortened dynein arms (HP:0200106) | 1.87433818 |
| 69 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87433818 |
| 70 | Abnormality of the ischium (HP:0003174) | 1.87380380 |
| 71 | Macular degeneration (HP:0000608) | 1.86875990 |
| 72 | Pigmentary retinal degeneration (HP:0001146) | 1.86465120 |
| 73 | Abnormality of renal excretion (HP:0011036) | 1.86210329 |
| 74 | Aplasia involving bones of the extremities (HP:0009825) | 1.85661513 |
| 75 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.85661513 |
| 76 | Aplasia of the phalanges of the hand (HP:0009802) | 1.85661513 |
| 77 | Pendular nystagmus (HP:0012043) | 1.83834399 |
| 78 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83791395 |
| 79 | Hyperkalemia (HP:0002153) | 1.83715410 |
| 80 | Nonprogressive disorder (HP:0003680) | 1.82891986 |
| 81 | Stomach cancer (HP:0012126) | 1.82279533 |
| 82 | Hypoplasia of the ulna (HP:0003022) | 1.79114025 |
| 83 | Gait imbalance (HP:0002141) | 1.78479517 |
| 84 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.78428238 |
| 85 | Nephritis (HP:0000123) | 1.78402074 |
| 86 | Abnormal urine output (HP:0012590) | 1.78363899 |
| 87 | Anencephaly (HP:0002323) | 1.78200357 |
| 88 | Tented upper lip vermilion (HP:0010804) | 1.77641493 |
| 89 | Congenital primary aphakia (HP:0007707) | 1.76549837 |
| 90 | Widely spaced teeth (HP:0000687) | 1.76465457 |
| 91 | Hypoplasia of the fovea (HP:0007750) | 1.73421589 |
| 92 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.73421589 |
| 93 | Nephrotic syndrome (HP:0000100) | 1.73331510 |
| 94 | Growth hormone deficiency (HP:0000824) | 1.71815916 |
| 95 | Optic nerve hypoplasia (HP:0000609) | 1.71530355 |
| 96 | Hypothermia (HP:0002045) | 1.70845708 |
| 97 | Alacrima (HP:0000522) | 1.70693727 |
| 98 | Infantile muscular hypotonia (HP:0008947) | 1.68969803 |
| 99 | Neonatal respiratory distress (HP:0002643) | 1.68868688 |
| 100 | Abnormal biliary tract physiology (HP:0012439) | 1.68806850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.24830625 |
| 2 | ADRBK2 | 2.90352541 |
| 3 | WNK3 | 2.47965645 |
| 4 | BMPR1B | 2.32679701 |
| 5 | GRK1 | 2.19229108 |
| 6 | EPHA3 | 2.10136052 |
| 7 | MAP4K2 | 2.06499598 |
| 8 | FGFR2 | 2.05497578 |
| 9 | MAPK15 | 2.05334638 |
| 10 | INSRR | 2.02476352 |
| 11 | DAPK2 | 2.00606384 |
| 12 | FER | 1.99222022 |
| 13 | STK38L | 1.88995123 |
| 14 | TAOK3 | 1.77804323 |
| 15 | PINK1 | 1.72448698 |
| 16 | ACVR1B | 1.72367591 |
| 17 | TIE1 | 1.58300374 |
| 18 | TNK2 | 1.53821258 |
| 19 | WNK4 | 1.51103126 |
| 20 | MAPK13 | 1.44243190 |
| 21 | NUAK1 | 1.40176176 |
| 22 | BLK | 1.36569993 |
| 23 | PTK2B | 1.33736974 |
| 24 | LATS1 | 1.33147675 |
| 25 | PAK3 | 1.32742390 |
| 26 | AKT3 | 1.31975392 |
| 27 | TLK1 | 1.30714917 |
| 28 | OXSR1 | 1.30703635 |
| 29 | IRAK1 | 1.30066755 |
| 30 | NLK | 1.22337362 |
| 31 | CASK | 1.18994742 |
| 32 | ERBB2 | 1.13112073 |
| 33 | MAP3K4 | 1.09995518 |
| 34 | MAPKAPK3 | 1.09801826 |
| 35 | ADRBK1 | 1.08245248 |
| 36 | PRKAA2 | 1.04384596 |
| 37 | HIPK2 | 1.04290301 |
| 38 | DYRK2 | 1.02488357 |
| 39 | PRKCE | 1.01217591 |
| 40 | CAMK1D | 0.96474738 |
| 41 | MYLK | 0.96362425 |
| 42 | SGK2 | 0.93419654 |
| 43 | PIK3CG | 0.90000447 |
| 44 | ZAK | 0.86474815 |
| 45 | MAP3K7 | 0.85067047 |
| 46 | STK3 | 0.80690539 |
| 47 | TXK | 0.80005911 |
| 48 | SGK223 | 0.78171707 |
| 49 | SGK494 | 0.78171707 |
| 50 | GRK5 | 0.76680723 |
| 51 | STK11 | 0.73521157 |
| 52 | MARK2 | 0.72813445 |
| 53 | STK39 | 0.72275453 |
| 54 | MAP2K6 | 0.69694874 |
| 55 | CHUK | 0.65250824 |
| 56 | NTRK3 | 0.63326247 |
| 57 | PIK3CA | 0.62909718 |
| 58 | TGFBR1 | 0.62086080 |
| 59 | CAMK1 | 0.62049407 |
| 60 | NME1 | 0.61251697 |
| 61 | RPS6KA6 | 0.61058207 |
| 62 | PKN1 | 0.58922061 |
| 63 | BRSK2 | 0.58457708 |
| 64 | TGFBR2 | 0.57661767 |
| 65 | CAMK1G | 0.57656871 |
| 66 | CDC42BPA | 0.57158461 |
| 67 | TNIK | 0.56496811 |
| 68 | MUSK | 0.55694584 |
| 69 | OBSCN | 0.55582891 |
| 70 | PRKD1 | 0.55533533 |
| 71 | MKNK2 | 0.55482298 |
| 72 | PRKCZ | 0.54276590 |
| 73 | EPHA4 | 0.52905051 |
| 74 | PRKACA | 0.52092121 |
| 75 | MAPK7 | 0.51040343 |
| 76 | PRKCG | 0.51002240 |
| 77 | EPHB2 | 0.50973713 |
| 78 | MAP2K7 | 0.49468608 |
| 79 | KDR | 0.49383939 |
| 80 | EPHB1 | 0.48580906 |
| 81 | PRKD2 | 0.46743016 |
| 82 | MARK1 | 0.46726820 |
| 83 | IKBKB | 0.46505653 |
| 84 | MATK | 0.45812709 |
| 85 | EPHA2 | 0.43829089 |
| 86 | TEC | 0.43473194 |
| 87 | GRK7 | 0.43239302 |
| 88 | PRKAA1 | 0.41762083 |
| 89 | CAMK4 | 0.41237205 |
| 90 | TRIM28 | 0.40792296 |
| 91 | CAMKK2 | 0.40529427 |
| 92 | MAP3K6 | 0.40047572 |
| 93 | VRK1 | 0.39757866 |
| 94 | CSNK1A1 | 0.39727140 |
| 95 | RPS6KA5 | 0.38194181 |
| 96 | CSNK1G1 | 0.36894928 |
| 97 | PRKCI | 0.36762895 |
| 98 | PRKG1 | 0.35595928 |
| 99 | PHKG2 | 0.35240371 |
| 100 | PHKG1 | 0.35240371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.18462979 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.11299613 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.77409415 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.67040748 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.40501130 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.32527245 |
| 7 | ABC transporters_Homo sapiens_hsa02010 | 2.13084526 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.04680608 |
| 9 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.04286113 |
| 10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.00670282 |
| 11 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.94650515 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.90845903 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.83088698 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71992889 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.70440722 |
| 16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.61712575 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.58606207 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.55233921 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48948694 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.35184359 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.31710516 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.27767208 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24586716 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.24483165 |
| 25 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.21968530 |
| 26 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21790145 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21501163 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17687576 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.17624089 |
| 30 | Nicotine addiction_Homo sapiens_hsa05033 | 1.16788280 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16432416 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.15563036 |
| 33 | Circadian entrainment_Homo sapiens_hsa04713 | 1.12538507 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12231267 |
| 35 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.10583514 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10138345 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08130372 |
| 38 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07123026 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 1.05163203 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03073906 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02891827 |
| 42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.01341950 |
| 43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01210284 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 0.96531328 |
| 45 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.95795085 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95454122 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92729539 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91806643 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90263569 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85715660 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85203107 |
| 52 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.82740141 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.82666403 |
| 54 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81293446 |
| 55 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81284699 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79932516 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79234032 |
| 58 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79068612 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78837856 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.76860291 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75386645 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.74301091 |
| 63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.73820219 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73168580 |
| 65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72471376 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72035636 |
| 67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69928440 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68016507 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67172838 |
| 70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67076665 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66048950 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65729314 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62006763 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61063128 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60718502 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60661046 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57515472 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.56825826 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56518352 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.55093559 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54068522 |
| 82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52734908 |
| 83 | Homologous recombination_Homo sapiens_hsa03440 | 0.52719859 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.52170926 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51933903 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49691436 |
| 87 | Melanoma_Homo sapiens_hsa05218 | 0.48236055 |
| 88 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47146629 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46605893 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45883143 |
| 91 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45570523 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45564773 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43719397 |
| 94 | Cocaine addiction_Homo sapiens_hsa05030 | 0.42819687 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42639024 |
| 96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42390582 |
| 97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42271119 |
| 98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40647894 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40633674 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37572912 |

